×
About 885 results

ALLMedicine™ Raynaud Phenomenon Center

Research & Reviews  284 results

Pediatric mixed connective tissue disease versus other overlap syndromes: a retrospecti...
https://doi.org/10.1007/s00296-023-05300-x
Rheumatology International; Batu ED, Günalp A et. al.

Mar 13th, 2023 - Pediatric mixed connective tissue disease (MCTD) is a subgroup of overlap syndromes. We aimed to compare the characteristics and outcomes in children with MCTD and other overlap syndromes. All MCTD patients met either Kasukawa or Alarcon-Segovia a...

Scleroderma
https://emedicine.medscape.com/article/331864-print

Mar 1st, 2023 - Practice Essentials The term scleroderma is derived from the Greek words skleros (hard or indurated) and derma (skin) and it is used to describe a disease characterized by progressive skin hardening and induration. Scleroderma is an aspect of syst...

Scleroderma Clinical Presentation
https://emedicine.medscape.com/article/331864-clinical

Mar 1st, 2023 - History Signs and symptoms of systemic sclerosis may involve the following systems: Skin [46, 47, 48] Vascular [49, 50, 51, 52, 53, 54, 55] Gastrointestinal (GI) [56, 57, 58, 59, 60, 61] Respiratory [62, 63, 64] Musculoskeletal [65, 66, 67, 68, 69...

Scleroderma
https://emedicine.medscape.com/article/331864-overview

Mar 1st, 2023 - Practice Essentials The term scleroderma is derived from the Greek words skleros (hard or indurated) and derma (skin) and it is used to describe a disease characterized by progressive skin hardening and induration. Scleroderma is an aspect of syst...

Scleroderma
http://emedicine.medscape.com/article/331864-overview

Mar 1st, 2023 - Practice Essentials The term scleroderma is derived from the Greek words skleros (hard or indurated) and derma (skin) and it is used to describe a disease characterized by progressive skin hardening and induration. Scleroderma is an aspect of syst...

see more →

Clinicaltrials.gov  18 results

Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk
https://clinicaltrials.gov/ct2/show/NCT05098704

Oct 18th, 2022 - In this study, platelet activation is targeted as it could play a key role in the pathogenesis of SSc. It has been shown in several publications that platelets are activated in SSc with a correlation between the level of activation and disease act...

RElevance of UltraSonography for Assessing Salivary Gland Involvement in Systemic Sclerosis (SSc)
https://clinicaltrials.gov/ct2/show/NCT04001556

Apr 5th, 2022 - Systemic sclerosis (SSc) is a rare autoimmune chronic disorder characterised by vascular hyper-reactivity and fibrosis of the skin as well as internal organs. Intimal hyperplasia, endothelial dysfunction and occlusive vasculopathy are the underlyi...

Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic Sclerosis
https://clinicaltrials.gov/ct2/show/NCT03717961

Feb 10th, 2022 - In SSc, RP is present in 95% of the patients. Despite cold avoidance, RP attacks are severe, painful, affecting the quality of life, with frequent severe ischemic symptoms such as digital ulcers. Treating patients with RP secondary to SSc is extre...

Evaluation of Effectiveness of Acetylsalicylic Acid on Markers of Vascular Dysfunction in Scleroderma Patients
https://clinicaltrials.gov/ct2/show/NCT03558854

Dec 1st, 2021 - Systemic sclerosis is a chronic autoimmune disease characterized by vascular changes in the microcirculation (small blood vessels) and progressive fibrosis of the skin and internal organs. It is believed that vascular changes, expressed early by t...

Observational Study on the Efficacy, Safety, and Tolerability of GAlcanezumab in Real Life Migraine Patients in ITaly
https://clinicaltrials.gov/ct2/show/NCT04803513

Mar 17th, 2021 - GARLIT is an independent, multicenter, prospective, cohort, real-life study. All consecutive patients aged 18 or older with a diagnosis of HFEM (8-14 migraine days per month) or CM (1.3 ICHD-3), who had failed at least three migraine preventive tr...

see more →

News  51 results

Morning Stiffness, Dry Eyes, Back Pain in a Fit 58-Year-Old
https://www.medscape.com/viewarticle/983148

Nov 10th, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

Cracking the “MGUS” Code Reveals Monoclonal Gammopathy of Clinical Significance:
https://www.onclive.com/view/cracking-the-mgus-code-reveals-monoclonal-gammopathy-of-clinical-significance-

Nov 1st, 2022 - When assessing monoclonal gammopathy it is important to rule out clinically significant associations requiring treatment. On initial patient consultation, gathering a detailed patient history and thorough physical exam can catch clinically signifi...

Scattered Flesh-Colored Papules in a Linear Array in the Setting of Diffuse Skin Thickening
https://www.mdedge.com/dermatology/article/257482/dermatopathology/scattered-flesh-colored-papules-linear-array-setting
Catherine Grace P. Hobayan, BS, Madison Grinnell, MD et. al.

Aug 31st, 2022 - The Diagnosis: Scleromyxedema A punch biopsy of the upper back performed at an outside institution revealed increased histiocytes and abundant interstitial mucin confined to the papillary dermis (Figures 1 and 2), consistent with the lichen myxede.

A case of cold, purple toes
https://www.mdedge.com/familymedicine/article/253770/dermatology/case-cold-purple-toes
MDedge Family Medicine;

Apr 14th, 2022 - A punch-biopsy was performed on the left second toe where the erythema was the most intense. It demonstrated classic findings for pernio: superficial and deep perivascular lymphocytic inflammation and papillary dermal edema on the acral surface.

Ulcer on the Leg
https://www.mdedge.com/dermatology/article/248220/mixed-topics/ulcer-leg
Joana Cruañes-Monferrer, MD, Eduardo Alias-Carrascosa, MD

Nov 3rd, 2021 - The Diagnosis: Calcinosis Cutis Due to Systemic Sclerosis Sine Scleroderma Laboratory evaluation was notable for high titers of antinuclear antibodies (>1/320; reference range, 0–1/80) and positive anticentromere antibodies. There were no other re.

see more →

Patient Education  1 results see all →